MedPath

Effects of Inspiratory Muscle Training on Type 2 Diabetes Mellitus Patients With Inspiratory Muscle Weakness

Not Applicable
Completed
Conditions
Diabetes Complications
Inspiratory Muscle Weakness
Interventions
Behavioral: Inspiratory muscle training
Behavioral: Inpiratory muscle training placebo
Registration Number
NCT00815178
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Brief Summary

The purpose of the study is to determine if inspiratory muscle training improves inspiratory muscle strength of type 2 diabetes mellitus patients with inspiratory muscle weakness.

Detailed Description

In congestive heart failure patients, inspiratory muscle weakness can be reversed by developing diaphragmatic hypertrophy through inspiratory muscle training, improving functional capacity and quality of life. In type 2 diabetes mellitus patients the frequency of inspiratory muscle weakness is unknown, as well as the response to inspiratory muscle training. For this reason, the present study evaluated the inspiratory muscle strength in type 2 diabetes mellitus patients and the effect of inspiratory muscle training on inspiratory muscle strength, pulmonary function, functional capacity and autonomic modulation assessed through heart rate variability.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • diabetes melittus
  • sedentary
  • inspiratory muscle weakness with PImax < 70% of the predicted
Exclusion Criteria
  • mass index > 33 kg/m2
  • exercise-induced asthma history
  • infectious disease
  • osteoarticular disease
  • regular alcohol or tobacco consumption in the past 6 months
  • cardiac disease
  • pulmonary disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Inspiratory muscle trainingInspiratory muscle training-
PlaceboInpiratory muscle training placebo-
Primary Outcome Measures
NameTimeMethod
Maximum inspiratory pressure8 weeks
Secondary Outcome Measures
NameTimeMethod
Peak exercise oxigen consumption8 weeks
pulmonary function8 weeks
autonomic modulation assessed by heart rate variability8 weeks

Trial Locations

Locations (1)

Hospital de Clínicas de Porto Alegre

🇧🇷

Porto Alegre, Rio Grande do Sul, Brazil

© Copyright 2025. All Rights Reserved by MedPath